Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-30

FDA Approved: PAXIL — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride), authorizing a generic version under the existing NDA. This action…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PAXIL (paroxetine hydrochloride)

Snippet

SUPPL AP for PAXIL (PAROXETINE HYDROCHLORIDE)